Cargando…

A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma

Background: Glioma is one of the major health problems worldwide. Biomarkers for predicting the prognosis of Glioma are still needed. Methods: The transcriptome data and clinic information on Glioma were obtained from the CGGA, TCGA, GDC, and GEO databases. The immune infiltration status in the clus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ming-Chun, Wu, Di, Sun, Hui, Wang, Lian-Kun, Chen, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497112/ https://www.ncbi.nlm.nih.gov/pubmed/36138874 http://dx.doi.org/10.3390/brainsci12091138

Ejemplares similares

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
por: Qian, Xi-Feng, et al.
Publicado: (2022)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
por: Zhao, Xu, et al.
Publicado: (2022)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
por: Wan, Yanzhi, et al.
Publicado: (2023)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

Transcription Factor Signatures May Predict the Prognosis and Status of the Immune Microenvironment of Primary Lower-Grade Gliomas
por: Liu, Peidong, et al.
Publicado: (2021)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
por: Yu, Huihan, et al.
Publicado: (2022)

Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma
por: He, Yongze, et al.
Publicado: (2022)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
por: Zheng, Yi, et al.
Publicado: (2021)

Identification of purity and prognosis‐related gene signature by network analysis and survival analysis in brain lower grade glioma
por: Xiong, Zujian, et al.
Publicado: (2020)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
por: Li, Jinxing, et al.
Publicado: (2021)

Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma
por: Liu, Zhizheng, et al.
Publicado: (2021)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
por: Fan, Kun, et al.
Publicado: (2017)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy
por: Yang, Guozheng, et al.
Publicado: (2022)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Li, Ganglei, et al.
Publicado: (2021)

Identification of an energy metabolism-related six-gene signature for distinguishing and forecasting the prognosis of low-grade gliomas
por: Liu, Guoli, et al.
Publicado: (2023)

A five‐microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower‐grade glioma
por: Zhang, Jian‐Hua, et al.
Publicado: (2020)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis
por: Guo, Yu-Duo, et al.
Publicado: (2023)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Feng, Shaobin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8t8i1hvc5da0qtdb7m3r1a3aj7